Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient

被引：48

作者：

Dorff, Tanya B.

Shazer, Ronald L.

Nepomuceno, Edward M.

Tucker, Steven J.

机构：

[1] Angeles Clin & Res Inst, Los Angeles, CA 90025 USA

[2] Univ Calif Los Angeles, David Gaffen Sch Med, Cedars Sinai Med Ctr, Div Hematol Oncol,Dept Med, Los Angeles, CA 90024 USA

来源：

CLINICAL GENITOURINARY CANCER | 2007年 / 5卷 / 05期

关键词：

adrenolytic therapy; chemotherapy; radiation therapy; second-line therapy;

D O I：

10.3816/CGC.2007.n.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The occurrence of prostate carcinoma in transsexual patients has rarely been reported. These cases present a unique challenge in that such patients are effectively receiving androgen deprivation therapy. By definition, their disease is androgen-independent prostate cancer, and the role of local therapy is undefined. We report on a male-to-female transsexual patient with metastatic prostate cancer treated successfully with combination chemotherapy after previous standard therapy failed.

引用

收藏

页码：344 / 346

页数：3

相关论文

共 16 条

[1] Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer [J].

Beer, TM ;

Eilers, KM ;

Garzotto, M ;

Egorin, MJ ;

Lowe, BA ;

Henner, WD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :123-128

[2]

Bostwick David G, 2004, Clin Prostate Cancer, V2, P228, DOI 10.3816/CGC.2004.n.004

[3]

BOSTWICK DG, 1994, AM J CLIN PATHOL S, V102, P38

[4] Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer [J].

Dahut, WL ;

Gulley, JL ;

Arlen, PM ;

Liu, Y ;

Fedenko, KM ;

Steinberg, SM ;

Wright, JJ ;

Parnes, H ;

Chen, CC ;

Jones, E ;

Parker, CE ;

Linehan, WM ;

Figg, WD .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) :2532-2539

[5] Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer [J].

Kelly, WK ;

Curley, T ;

Slovin, S ;

Heller, G ;

McCaffrey, J ;

Bajorin, D ;

Ciolino, A ;

Regan, K ;

Schwartz, M ;

Kantoff, P ;

George, D ;

Oh, W ;

Smith, M ;

Kaufman, D ;

Small, EJ ;

Schwartz, L ;

Larson, S ;

Tong, W ;

Scher, H .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :44-53

[6] RADIOTHERAPY FOR REGIONALLY LOCALIZED HORMONE-REFRACTORY PROSTATE-CANCER [J].

LANKFORD, SP ;

POLLACK, A ;

ZAGARS, GK .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (04) :907-912

[7] A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma - Cancer and leukemia group B 99813 [J].

Oh, WK ;

Halabi, S ;

Kelly, WK ;

Werner, C ;

Godley, PA ;

Vogelzang, NJ ;

Small, EJ .

CANCER, 2003, 98 (12) :2592-2598

[8] ESTRAMUSTINE PHOSPHATE SODIUM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PROSTATE-CANCER [J].

PERRY, CM ;

MCTAVISH, D .

DRUGS & AGING, 1995, 7 (01) :49-74

[9] Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer [J].

Petrylak, DP ;

Tangen, CM ;

Hussain, MHA ;

Lara, PN,J ;

Jones, JA ;

Taplin, ME ;

Burch, PA ;

Berry, D ;

Moinpour, C ;

Kohli, M ;

Benson, MC ;

Small, EJ ;

Raghavan, D ;

Crawford, ED .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1513-1520

[10] COMPARISON OF MAGNETIC-RESONANCE-IMAGING AND ULTRASONOGRAPHY IN STAGING EARLY PROSTATE-CANCER - RESULTS OF A MULTIINSTITUTIONAL COOPERATIVE TRIAL [J].

RIFKIN, MD ;

ZERHOUNI, EA ;

GATSONIS, CA ;

QUINT, LE ;

PAUSHTER, DM ;

EPSTEIN, JI ;

HAMPER, U ;

WALSH, PC ;

MCNEIL, BJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (10) :621-626